Valuation : Zai Lab Limited

Market Cap 284.03Cr 245.04Cr 230.83Cr 210.31Cr 393.11Cr 27TCr 396.06Cr 2.73TCr 1.06TCr 14TCr 1.07TCr 1.04TCr 45TCr P/E 2026 *
-11.5x
P/E 2027 * -11.4x
Enterprise Value 238.27Cr 205.55Cr 193.64Cr 176.43Cr 329.77Cr 23TCr 332.24Cr 2.29TCr 889.69Cr 12TCr 894.72Cr 875.16Cr 38TCr EV / Sales 2026 *
5.64x
EV / Sales 2027 * 4.34x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day+3.20%
1 week+0.27%
Current month+2.51%
1 month+43.56%
3 months+52.19%
6 months+41.69%
Current year+47.96%
1 week 24.81
Extreme 24.81
27.5
1 month 18.15
Extreme 18.15
27.5
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
34.72
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
152.82
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
19/08/26 Sell

Chief Financial Officer

-260 0.0000%
14/08/26 Exercice

Chief Financial Officer

2,927 0.0003%
12/08/26 Other

Director

-85,060 0.0075%
Change 5-day change 1-year change 3-year change Capi.($)
+3.30%+0.27%-21.72%-8.87% 284.03Cr
+2.96%+3.92%+46.51%+2.89% 8.23TCr
-3.61%-0.83%+513.56%+35.72% 6.16TCr
+0.89%+0.12%-17.32%-35.39% 5.9TCr
-1.25%-5.30%-1.98%+33.18% 5.12TCr
+0.92%-0.23%+11.50%+169.82% 4.83TCr
+3.05%+0.51%+59.13%-16.56% 3.19TCr
+1.92%-0.85%+47.74%+100.74% 2.53TCr
+0.20%+1.70%-3.42%+190.03% 2.26TCr
-0.52%-1.98%+65.45%+110.84% 1.66TCr
Average +0.69%-2.58%+69.95%+58.24% 4.02TCr
Weighted average by Cap. +0.41%-2.78%+96.93%+45.74%

Financials

2026 *2027 *
Net sales 42Cr 36Cr 34Cr 31Cr 59Cr 3.99TCr 59Cr 406.75Cr 157.86Cr 2.04TCr 158.75Cr 155.28Cr 6.71TCr 57Cr 49Cr 46Cr 42Cr 78Cr 5.35TCr 79Cr 544.75Cr 211.41Cr 2.73TCr 212.61Cr 207.96Cr 8.98TCr
Net income -24Cr -21Cr -20Cr -18Cr -33Cr -2.27TCr -34Cr -231.55Cr -90Cr -1.16TCr -90Cr -88Cr -3.82TCr -19Cr -16Cr -16Cr -14Cr -26Cr -1.8TCr -27Cr -183.7Cr -71Cr -922.14Cr -72Cr -70Cr -3.03TCr
Net Debt -46Cr -39Cr -37Cr -34Cr -63Cr -4.32TCr -64Cr -440.33Cr -170.89Cr -2.21TCr -171.85Cr -168.1Cr -7.26TCr -38Cr -33Cr -31Cr -28Cr -53Cr -3.6TCr -53Cr -366.4Cr -142.2Cr -1.84TCr -143Cr -139.87Cr -6.04TCr
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
03/26/03 $26.35 +4.15% 7,37,425
01/26/01 $25.30 -0.63% 9,79,939
31/26/31 $25.46 -2.38% 9,20,145
28/26/28 $26.08 -2.76% 6,50,041
27/26/27 $26.82 +3.03% 5,97,330
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.30USD
Average target price
33.14USD
Spread / Average Target
+30.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock